The Effect of Methods Used in Oral Antipyretic Administration on the Vital Findings of the Child With Fever
NCT ID: NCT05366049
Last Updated: 2022-12-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
100 participants
INTERVENTIONAL
2020-11-01
2022-08-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
using a medicine pacifier to give acetaminophen
using a medicine pacifier to give acetaminophen
While giving acetaminophen, the effect on the amount of taking the drug, pain and vital parameters are observed by using the drug pacifier.
using an enjector to give acetaminophen
using a medicine pacifier to give acetaminophen
While giving acetaminophen, the effect on the amount of taking the drug, pain and vital parameters are observed by using the drug pacifier.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
using a medicine pacifier to give acetaminophen
While giving acetaminophen, the effect on the amount of taking the drug, pain and vital parameters are observed by using the drug pacifier.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Being prescribed an antipyretic (paracetamol) by a physician.
* Those whose parents are literate and agree to participate in the study.
* Patients with triage color classification Yellow and Green.
* Children between 0-24 months will be included in the study.
Exclusion Criteria
* Being prescribed an antipyretic other than paracetamol by the physician.
* Having trouble in sucking-swallowing coordination.
* Children with chronic disease and neuromotor developmental delay.
24 Months
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istanbul University - Cerrahpasa
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sermin Dİnç
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Istanbul Unisversity- Cerrahpasa
Istanbul, Fatih, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
E-59491012-604.01.02-2973
Identifier Type: -
Identifier Source: org_study_id